Pharmacy: Final stage agreement with Medicare

Posted on February 17, 2022 17:00Updated February 17th. 2022 17:09

The final straight line for negotiations on new pharmaceutical contracts. Pharmacists, Medicare and alternative medicine have almost reached an agreement with funding of € 120-180 million.

They need to discuss again next week to reach a conclusion or to disband, as Medicare is still stumbling upon an increase in reimbursement for high-capacity medicine boxes that it wants to make up for with price cuts. The board of directors of the French Pharmaceutical Union Federation (59% of the votes), a majority union, examined Medicare’s proposal this Thursday, provided that the € 30 million mortgage was lifted.

A new dimension

If they do well, the pharmacist profession will take a new dimension. In fact, traditional partners want to allow specialists to prescribe and inject most of the available vaccines for patients over the age of 16. This is what the Higher Health Department recommends in an opinion released in January. Only vaccination against rabies and meningococcus B is excluded.

Pharmacists have recently established their position by vaccination of the elderly with flu health insurance vouchers and then by placing a pharmacy in the service of vaccination campaigns against Covid.

Same price as a doctor for vaccination

The reward for the act of vaccination will be € 9.60, as in the case of a doctor. If the pharmacist does not prescribe (because the patient already has a voucher or prescription), the price will drop to € 7.50. These fees include the fee for filling out the electronic care sheet. You don’t have to enter the information again to fill out the new National Digital Health Record “My Health Space”.

This measure, like other pharmaceutical contracts, has a mandatory six-month deadline and will not be effective until October.

In addition, pharmacists will be paid € 6 per act for screening for colorectal cancer and cystitis, including € 1 for the purchase of equipment. Higher health agencies have also given a green light to such decisions. On the other hand, screening for diabetes and cardiovascular disease has high economic interests, and it is necessary to wait for negotiations on an amendment scheduled for 2023.

Social partners will take advantage of this new conference to explore the economic model of pharmacies. It has also been turned upside down by the Covid crisis and can now make major decisions.

Push of “Digital Ségur” software

In addition, if current negotiations are successful, pharmacists will be rewarded to detect the risk of harmful drug interactions in pregnant women and accompany them by bringing the drug to the inpatient’s return home (Prado program). “It’s not as interesting as the new organization, which has CPAM medical advisors who can call pharmacists to arrange returns,” emphasizes Philippe Besset, chairman of the pharmaceutical union FSPF.

This new contract is also valuable to public institutions that are encouraging the adoption of new business software compatible with the “Ségur du numérique” standard by all healthcare professionals. They will be available in pharmacies at the end of the year. For each pharmacy equipped, not only the software publisher but also the pharmacist is paid a fixed annual price for the Public Health Goal (ROSP).

In addition, pharmacists are economically motivated to dispense antibiotics on a unit-by-unit basis. This is almost always less attractive to pharmacists.